NCT03398863

Brief Summary

400 women who came to our Department for Cesarean Section delivery will be divided into 2 groups: Group1:Cleaning the uterine cavity "200 patients" Group2:No Cleaning of uterine cavity "200 patients"

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable pregnancy

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 16, 2018

Completed
20 days until next milestone

Study Start

First participant enrolled

February 5, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

February 27, 2018

Status Verified

February 1, 2018

Enrollment Period

5 months

First QC Date

December 28, 2017

Last Update Submit

February 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postpartum endometritis

    Endomyometritis after delivery \[ Time Frame: Within 6 weeks after delivery \] Endomyometritis will be diagnosed by the presence of two or more of the following: abnormally tender uterus on examination, temperature more than 38.0°C at any time postoperatively, and unexplained maternal tachycardia more than 100 beats per minute (bpm). A diagnosis of endomyometritis will be criteria for initiating treatment with antibiotics. Endomyometritis after delivery \[ Time Frame: Within 6 weeks after delivery \] Endomyometritis will be diagnosed by the presence of two or more of the following: abnormally tender uterus on examination, temperature more than 38.0°C at any time postoperatively, and unexplained maternal tachycardia more than 100 beats per minute (bpm). A diagnosis of endomyometritis will be criteria for initiating treatment with antibiotics.

    Within weeks

Secondary Outcomes (1)

  • Primary postpartum hemorrhage

    Within 6 weeks

Study Arms (2)

Cleaning of uterine cavity

ACTIVE COMPARATOR

Cleaning of uterine cavity: participants will have their uterine cavities cleaned with a dry laparotomy sponge after delivery of the placenta. Per standard protocol, the uterus will be explored with one hand holding a sponge to remove any remaining membranes or placental tissue, while the other hand is placed on the fundus to stabilize the uterus

Procedure: Cleaning of uterine cavity

Not cleaning of uterine cavity

NO INTERVENTION

These participants will have their uterine cavities left alone after complete delivery of the placenta. The placenta will be inspected after delivery to make sure it is complete, including the membranes.

Interventions

Procedure: Cleaning the uterine cavity These participants will have their uterine cavities cleaned with a dry laparotomy sponge after delivery of the placenta. Per standard protocol, the uterus will be explored with one hand holding a sponge to remove any remaining membranes or placental tissue, while the other hand is placed on the fundus to stabilize the uterus

Cleaning of uterine cavity

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • women age from 20 to35 years old with intact membrane women with singleton or multiple pregnancy women with cephalic or breech presentation

You may not qualify if:

  • premature rupture of membranes chorioamnionitis Diabetes mellitus Immunosuppressive disorder or therapy Fetal demise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ain shams University

Cairo, 02, Egypt

RECRUITING

Faculty of Medicine-Ainshams University

Cairo, 02, Egypt

NOT YET RECRUITING

Study Officials

  • Dr yasser Abou talib

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr yasser Abou talib, Professor

CONTACT

Dr ahmed Hussein, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

December 28, 2017

First Posted

January 16, 2018

Study Start

February 5, 2018

Primary Completion

July 1, 2018

Study Completion

December 1, 2018

Last Updated

February 27, 2018

Record last verified: 2018-02

Locations